Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- The team shrank two years in a row.
Revenue
€ 21,000
▼ 89% vs 2024
Profit
Caution€ -564,911
▲ 91% vs 2024
Debts
Low€ 1.7 million
▼ 76% vs 2024
Celyad Oncology from Mont-Saint-Guibert, company number BE0891118115, closed financial year 2025 with a result of € -564,911 after tax. For that financial year Celyad Oncology recorded revenue of € 21,000 and equity of € 2.2 million. Compared with financial year 2024, the result moved from € -6.4 million to € -564,911. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.
What happened at Celyad Oncology?
What happened at Celyad Oncology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Serge Goblet stepped down as director. NBB
- Christopher Lipuma stepped down as director. NBB
- Marina Udier stepped down as director. NBB
- Matthew Kane stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 564,911. Source: NBB ↗
- CFIP CLYD LLC stepped down as director. NBB
- Jonathan James stepped down as director. NBB
- HILDE WINDELS BV stepped down as director. NBB
In short
From € 29.5 million loss in 2021 to € 564,911 loss in 2025.
Paid € 1.2 million in corporate taxes since 2021.
Pays suppliers within 58 days on average.
A new publication or filing at Celyad Oncology? We notify you, reason included.
Follow Celyad OncologyNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by CFIP CLYD LLC (58.5%) and Tolefi SA (9.4%). It owns 100% of Celyad Inc and 100% of Corquest Medical itself.
Directors
According to the 2025 annual accounts
Serge Goblet
Director
since 2020 · until 2027
Ami Patel Shah
Director
since 2021 · until 2025
CFIP CLYD LLC
Director · represented by Michel Lussier
since 2023 · until 2026
Jonathan James
Director
since 2023 · until 2026
Chairman of the board · represented by Hilde Windels
Also active at: Gimv, MDxHealth, Healis Holding
since 2023 · until 2026
Christopher Lipuma
Director
since 2022 · until 2027
Marina Udier
Director
since 2020 · until 2027
Andrea Gothing
Director
since 2023 · until 2025
Sharon Roberg-Perez
Director
since 2025 · until 2026
Dominic Piscitelli
Director
since 2020 · until 2026
Sage Mandel
Director
since 2023 · until 2026
Matthew Kane
Director, Managing director
since 2024 · until 2027
Shareholders
CFIP CLYD LLC
58.5%
9.4%
Participations
100%
100%
Establishments
Establishment units
Physical locations of this company
Rue Emile Francqui 6
1435 Mont-Saint-Guibert
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
DERONGY
€ 99,503 gross margin · 2025
3L INTERNATIONAL
€ 221,227 gross margin · 2025
EXYRO
€ 572,448 gross margin · 2025
SYNERGIA MEDICAL
€ -3.1 million gross margin · 2025
DIGITEAL
€ 385,953 gross margin · 2025
+12 more
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
GOOGLE - Google LLC, US
Domain
Domain
celyad.com
Registered
2015-02-12
Registrar
IP Twins SAS
Expires
2027-02-12
Website info
Features
Security
Details
- Company number
- 0891.118.115
- VAT number
- BE 0891.118.115
- Registered office
- Rue Emile Francqui 6, 1435 Mont-Saint-Guibert
- Names & denominations
- Celyad Oncology
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 24 July 2007
- Peppol
- Active · Active since 16 Jan 2026
- Contact
- celyad.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige diensten , n.e.g.
Overige persoonlijke diensten